Waldo Concepcion
Publication Details
-
Use of basiliximab with mycophenolate mofetil in kidney transplantation.
Transplant Proc. 2003; (8): 2881-4
Randomized, placebo-controlled studies have determined that administration of basiliximab (chimeric IL-2 receptor antagonist) decreases the acute rejection rate in kidney transplantation when used in combination with cyclosporine, azathioprine, and steroids. We report our experience using basiliximab with mycophenolate mofetil, a calcineurin inhibitor, and steroids in kidney transplantation.
Help